文献速递精神分裂症与精神病性障碍心境障碍儿童青少年精神

精神病性体验的遗传易感性与神经精神障碍及特质的关联

Association of Genetic Liability to Psychotic Experiences With Neuropsychotic Disorders and Traits.
PubMed 文献 · JAMA Psychiatry · 2019-01-01

多基因风险评分分析显示其与重性抑郁障碍、精神分裂症、双相障碍、孤独症谱系障碍和注意缺陷多动障碍的遗传易感性相关。携带精神病性体验者具有既往与精神分裂症及神经发育障碍相关的拷贝数变异负荷增加。全基因组关联研究识别出4个显著关联位点,包括ANK3和CNR2基因位点。

要点

  • 精神病性体验与精神分裂症、重性抑郁障碍、双相障碍及神经发育障碍共享遗传易感性。
  • 精神病性体验者中与精神分裂症相关的拷贝数变异负荷增加(OR 2.04)。
  • 全基因组关联研究识别出4个显著位点,包括ANK3和CNR2。

核心结论

  • 精神病性体验与精神分裂症、重性抑郁障碍、双相障碍和神经发育障碍存在共享遗传易感性。

主要发现

  • 精神病性体验与重性抑郁障碍、精神分裂症、孤独症谱系障碍和注意缺陷多动障碍存在遗传相关。
  • 多基因风险评分分析显示精神病性体验与重性抑郁障碍、精神分裂症、双相障碍、孤独症谱系障碍和注意缺陷多动障碍的遗传易感性相关。
  • 报告精神病性体验者具有既往与精神分裂症相关的拷贝数变异负荷增加(OR 2.04;95% CI 1.39-2.98;P=2.49×10^-4)及与神经发育障碍更广泛相关的拷贝数变异负荷增加(OR 1.75;95% CI 1.24-2.48;P=1.41×10^-3)。
  • 全基因组关联研究识别出4个显著关联位点,包括ANK3位点与任何精神病性体验相关(OR 1.16;95% CI 1.10-1.23;P=3.06×10^-8),CNR2位点与困扰性精神病性体验相关(OR 0.66;95% CI 0.56-0.78;P=3.78×10^-8)。
  • 任何精神病性体验的全基因组关联研究基于单核苷酸多态性的遗传率估计较低(h2=1.71%;95% CI 1.02%-2.40%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Psychotic experiences, such as hallucinations and delusions, are reported by approximately 5% to 10% of the general population, although only a small proportion develop psychotic disorders such as schizophrenia. Studying the genetic causes of psychotic experiences in the general population, and its association with the genetic causes of other disorders, may increase the understanding of their pathologic significance. OBJECTIVES: To determine whether genetic liability to psychotic experiences is shared with schizophrenia and/or other neuropsychiatric disorders and traits and to identify genetic loci associated with psychotic experiences. DESIGN, SETTING AND PARTICIPANTS: Analyses of genetic correlation, polygenic risk scores, and copy number variation were performed using data from participants in the UK Biobank from April 1, 2018, to March 20, 2019, to assess whether genetic liability to psychotic experiences is shared with schizophrenia and/or other neuropsychiatric disorders and traits. Genome-wide association studies of psychotic experience phenotypes were conducted to identify novel genetic loci. Participants in the final analyses after exclusions included 6123 individuals reporting any psychotic experience, 2143 individuals reporting distressing psychotic experiences, and 3337 individuals reporting multiple occurrences of psychotic experiences. A total of 121 843 individuals who did not report a psychotic experience formed the comparator group. Individuals with a psychotic disorder were excluded from all analyses. MAIN OUTCOMES AND MEASURES: Genetic associations with psychotic experience phenotypes. RESULTS: The study included a total of 127 966 participants (56.0% women and 44.0% men; mean [SD] age, 64.0 [7.6] years). Psychotic experiences were genetically correlated with major depressive disorder, schizophrenia, autism spectrum disorder, and attention-deficit/hyperactivity disorder. Analyses of polygenic risk scores identified associations between psychotic experiences and genetic liability for major depressive disorder, schizophrenia, bipolar disorder, autism spectrum disorder, and attention-deficit/hyperactivity disorder. Individuals reporting psychotic experiences had an increased burden of copy number variations previously associated with schizophrenia (odds ratio [OR], 2.04; 95% CI, 1.39-2.98; P = 2.49 × 10-4) and neurodevelopmental disorders more widely (OR, 1.75; 95% CI, 1.24-2.48; P = 1.41 × 10-3). Genome-wide association studies identified 4 significantly associated loci, including a locus in Ankyrin-3 (ANK3 [GenBank NM_020987]) (OR, 1.16; 95% CI, 1.10-1.23; P = 3.06 × 10-8) with any psychotic experience, and a locus in cannabinoid receptor 2 gene (CNR2 [GenBank NM_001841]) (OR, 0.66; 95% CI, 0.56-0.78; P = 3.78 × 10-8) with distressing psychotic experiences. The genome-wide association study of any psychotic experience had a low single-nucleotide polymorphism-based heritability estimate (h2 = 1.71%; 95% CI, 1.02%-2.40%). CONCLUSIONS AND RELEVANCE: A large genetic association study of psychotic experiences from the population-based UK Biobank sample found support for a shared genetic liability between psychotic experiences and schizophrenia, major depressive disorder, bipolar disorder, and neurodevelopmental disorders.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Legge SE, Jones HJ, Kendall KM, et al. Association of Genetic Liability to Psychotic Experiences With Neuropsychotic Disorders and Traits. JAMA Psychiatry. 2019. PMID: 31553412. doi:10.1001/jamapsychiatry.2019.2508

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。